A practical reference on lyophilised powder: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-07-18 and is reviewed periodically as new material appears.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
| Property | Value | Notes |
|---|---|---|
| Dosage form | Lyophilized powder in sealed vial | Reconstituted before analytical or laboratory use |
| Reconstitution solvent | Sterile or bacteriostatic water | Bacteriostatic water limits microbial growth in multi-use vials |
| Typical working pH | Near neutral, buffered | Strongly acidic or basic conditions promote degradation |
| Stability indicator | Loss of main HPLC peak over time | Aggregation and oxidation are common degradation routes |
| Documentation | Batch certificate of analysis | Covers identity, purity and sometimes sterility testing |
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
== Eponym == Donohue syndrome was first identified in 1948 by Canadian pathologist William L. Donohue (1906–1985). The name leprechaunism has been largely abandoned because of the perception of the name by some parents of patients as insulting.
Skin hydration and surface lipids, on the other hand, did not significantly change with topical progesterone. These findings suggest that progesterone, like estrogen, also has beneficial effects on the skin and may be independently protective against skin aging.
== PEGylated drugs == The attachment of an inert and hydrophilic polymer was first reported around 1970 to extend blood life and control immunogenicity of proteins. Polyethylene glycol was chosen as the polymer. In 1981 Davis and Abuchowski founded Enzon, Inc., which brought three PEGylated drugs to market. Abuchowski later founded and is CEO of Prolong Pharmaceuticals. The clinical value of PEGylation is now well established. ADAGEN (pegademase bovine) manufactured by Enzon Pharmaceuticals, Inc., US was the first PEGylated protein approved by the U.S. Food and Drug Administration (FDA) in March 1990, to enter the market. It is used to treat a form of severe combined immunodeficiency syndrome (ADA-SCID), as an alternative to bone marrow transplantation and enzyme replacement by gene therapy. Since the introduction of ADAGEN, a large number of PEGylated protein and peptide pharmaceuticals have followed and many others are under clinical trial or under development stages. Sales of the two most successful products, Pegasys and Neulasta, exceeded $5 billion in 2011. All commercially available PEGylated pharmaceuticals contain methoxypoly(ethylene glycol) or mPEG. PEGylated pharmaceuticals on the market (in reverse chronology by FDA approval year) have included:
The International Journal of Mass Spectrometry is a monthly peer-reviewed scientific journal covering all aspects of mass spectrometry, including instrumentation and applications in biology, chemistry, geology, and physics. It was established in 1968 as the International Journal of Mass Spectrometry and Ion Physics and was renamed International Journal of Mass Spectrometry and Ion Processes in 1983, before obtaining its current title in 1998. It is published by Elsevier and the editors-in-chief are Julia Laskin (Purdue University) and Zheng Ouyang (Tsinghua University).
== Abstracting and indexing == Xenobiotica is abstracted and indexed in Biochemistry and Biophysics Citation Index, BIOSIS, Chemical Abstracts; Current Contents/Life Science, EBSCO, Science Citation Index, PASCAL, SciSearch, Scopus, and Index Medicus/MEDLINE/PubMed.
Sources: en.wikipedia.org
==== Absorption ==== Enobosarm is orally bioavailable due to a lack of extensive first-pass metabolism. In rats, the oral bioavailability of enobosarm was found to be 100%. Enobosarm is rapidly absorbed with oral administration and reaches maximal concentrations median 1.0 hours (range 1.0–2.0 hours) following administration. The drug reaches a peak concentration of 56.0 ng/mL (range 53.1–123.0 ng/mL) following a single 3 mg dose and a steady-state peak of 68.1 ng/mL following repeated 3 mg doses. The pharmacokinetics of enobosarm are linear and proportional over a dose range of 1 to 100 mg in single doses in healthy men. The pharmacokinetics of enobosarm are similar in young versus elderly individuals. A concentration–time curve of enobosarm levels following a single oral dose of enobosarm in humans has been published.
=== High-speed === By 1982 the technology was sufficiently advanced for the technique to be called "high-speed" countercurrent chromatography (HSCCC). Peter Carmeci initially commercialized the PC Inc. Ito Multilayer Coil Separator/Extractor which utilized a single bobbin (onto which the coil is wound) and a counterbalance, plus a set of "flying leads" which are tubing that connect the bobbins. Dr. Walter Conway & others later evolved the bobbin design such that multiple coils, even coils of different tubing sizes, could be placed on the single bobbin. Edward Chou later evolved and commercialized a triple bobbin design as the Pharmatech CCC which had a de-twist mechanism for leads between the three bobbins. The Quattro CCC released in 1993 further evolved the commercially available instruments by utilizing a novel mirror image, twin bobbin design that did not need the de-twist mechanism of the Pharmatech between the multiple bobbins, so could still accommodate multiple bobbins on the same instrument. Hydrodynamic CCC are now available with up to 4 coils per instrument. These coils can be in PTFE, PEEK, PVDF, or stainless steel tubing. The 2, 3 or 4 coils can all be of the same bore to facilitate "2D" CCC (see below). The coils may be connected in series to lengthen the coil and increase the capacity, or the coils may be linked in parallel so that 2, 3, or 4 separations may be done simultaneously. The coils can also be of different sizes, on one instrument, ranging from 1 to 6 mm on one instrument, thus allowing a single instrument to optimize from mg to kilos per day.
The induced fit concept cannot be used to rationalize catalysis. That is, the chemical catalysis is defined as the reduction of Ea‡ (when the system is already in the ES‡) relative to Ea‡ in the uncatalyzed reaction in water (without the enzyme). The induced fit only suggests that the barrier is lower in the closed form of the enzyme but does not tell us what the reason for the barrier reduction is. Induced fit may be beneficial to the fidelity of molecular recognition in the presence of competition and noise via the conformational proofreading mechanism. However, the role of induced fit in controlling replication fidelity has been questioned and remains poorly defined. Experimental and theoretical analyses have suggested that induced fit alone does not provide a sufficient explanation for high replication fidelity.
== Names == The prodrug candesartan cilexetil is marketed by AstraZeneca and Takeda Pharmaceuticals, commonly under the trade names Blopress, Atacand, Amias, and Ratacand. It is available in generic form.
== Research == Since the termination of its development as an antilipidemic agent, there has been renewed interest in potential repurposing of avasimibe as an antitumor drug and to prevent or treat bacterial infections by decreasing bacterial virulence. As of 2022, these potential indications remain in preclinical research.
Sources: en.wikipedia.org
==== Hydroxyurea ==== Hydroxyurea is another drug that can sometimes be administered to relieve anemia caused by beta-thalassemia. This is achieved, in part, by reactivating fetal haemoglobin production; however its effectiveness is uncertain.
Nancy's bottom-half finish proved a false dawn as the club finished 18th in the 1985–86 season, which meant they had to win a play-off match to avoid relegation. They retained their league status with a 3–2 aggregate win against Mulhouse. The club however sold several of their best players to avoid financial predicament and provided Wenger with little funds to work with. In Wenger's final season in charge, Nancy finished 19th and were relegated to Ligue 2. Despite the setbacks, he was contacted by Monaco over their vacant managerial job. Talks had begun during the summer of 1986, but Nancy chairman Gérard Rousselot refused to release Wenger from his contract, and Monaco were not prepared to offer compensation. Once Nancy's relegation was confirmed, Wenger was permitted to leave the club by mutual consent and was confirmed as Monaco manager in 1987. Before joining Monaco, Wenger had identified several players to build his desired team. Tottenham Hotspur midfielder Glenn Hoddle, granted a free transfer, and Patrick Battiston, out of contract at Bordeaux, were signed. Striker Mark Hateley left Milan to join Monaco and was "encouraged to learn" that his fellow Englishman Hoddle would play in the same side as him. Monaco won the league in Wenger's debut season, six points ahead of runners-up Bordeaux. Although the team scored more goals in 1988–89 due to the purchase of Liberian striker George Weah, Monaco failed to retain the league and finished third behind Marseille and Paris Saint-Germain.
=== Mineral resources === Ningxia is rich in mineral resources with proven deposits of 34 kinds of minerals, much of which located in grassland areas. In 2011 it was estimated that the potential value per capita of these resources accounted for 163.5 percent of the nation's average. Ningxia boasts verified coal reserves of over 30 billion tons, with an estimated reserve of more than 202 billion tons, ranking sixth nationwide. Coal deposits are spread over one-third of the total surface of Ningxia, and mined in four major fields in the Helan and Xiangshan mountains, Ningdong and Yuanzhou (or Guyuan). The region's reserves of oil and natural gas can be found in Yanchi and Lingwu County, and are ideal for large-scale development of oil, natural gas and chemical industries. Ningxia leads China in gypsum deposits, with a proven reserve of more than 4.5 billion tons, of which the rarely found, top-grade gypsum accounts for half of the total deposits. The Hejiakouzi deposit in Tongxin County features a reserve of 20 million tons of gypsum with a total thickness of 100 meters. There is a considerable deposit of quartz sandstone, of which 17 million tons have been ascertained. In addition, there are phosphorus, flint, copper, iron, barite, other minerals and Helan stone – a special clay stone.
==== Quantum dot only solar cells ==== Aromatic self-assembled monolayers (SAMs) (such as 4-nitrobenzoic acid) can be used to improve the band alignment at electrodes for better efficiencies. This technique has provided a record power conversion efficiency (PCE) of 10.7%. The SAM is positioned between ZnO–PbS colloidal quantum dot (CQD) film junction to modify band alignment via the dipole moment of the constituent SAM molecule, and the band tuning may be modified via the density, dipole and the orientation of the SAM molecule.
YY.com, a major Chinese social network yy (digraph), digraph used in various Latin alphabets Yy (musician), Canadian musician YY, the call sign prefix for radio stations in Venezuela Y. Y., pseudonym of Robert Wilson Lynd (1879–1949), Irish essayist Peptide YY 3-36, a peptide secreted by the gut in response to a meal, and reduces appetite The Space Pirates, a 1969 Doctor Who serial (production code YY)
Sources: en.wikipedia.org
Desiccated storage at −20 °C is conventional, with −80 °C for extended periods. Vials should be warmed to room temperature before opening to prevent condensation on the powder.
It usually reports batch-specific results for purity by chromatography, identity by mass spectrometry, and sometimes peptide content and residual solvents. It applies only to the batch tested, not to a supplier's wider stock.
Purity describes the proportion of the chromatographic signal from the target compound, while peptide content measures how much of the vial's physical mass is peptide. Counter-ions, water and residual acid make up the remainder, so content values are commonly lower.
No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.